This study investigates pancreatic cancer in individuals diagnosed at a young age. The purpose is to collect detailed clinical and genetic information from patients who have been diagnosed with pancreatic cancer at or before the age of 55.
The study focuses on gathering data to understand the disease better and support future research. It evaluates clinical outcomes and genetic factors associated with pancreatic cancer.
- Who can participate: Adults aged 18 to 55 years diagnosed with pancreatic cancer can participate. Participants must provide written informed consent.
- Study details: Participants will have their clinical and genetic data collected for the registry.
How understandable was the trial content above?
Hard to understand
Easy to understand